Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial

Journal of Hepatology
Savino BrunoGiovanbattista Pinzello

Abstract

We assessed the effectiveness and safety of an induction dose of peginterferon alfa-2b (PEG-IFN) plus ribavirin for initial treatment of patients with genotype 1 chronic HCV infection in a randomized, controlled, multicenter trial. Three hundred and eleven naïve patients infected with genotype 1 and chronic hepatitis were randomly assigned to 48-week treatment with PEG-IFN once weekly (80-100 micrograms depending on body weight for 8 weeks, followed by 50 micrograms for the next 40 weeks), or standard interferon alfa-2b (IFN) 6 million units on alternate days, both in combination with ribavirin (1000-1200 mg/day). PEG-IFN plus ribavirin significantly increased sustained virological response (SVR) compared with IFN plus ribavirin (41.1 vs. 29.3% respectively, P=0.030). Less patients discontinued PEG-IFN than IFN (19 vs. 31%, P=0.010). By logistic regression, SVR in the PEG-IFN group was independently associated with age <50 years, and mild fibrosis at liver biopsy. Combination therapy with an induction dose of PEG-IFN was a more effective and better tolerated treatment for naïve patients with genotype 1 than combination therapy with high dose standard IFN. In patients aged less than 50 years with mild fibrosis this schedule achi...Continue Reading

References

Aug 1, 1967·Journal of Chronic Diseases·D Schwartz, J Lellouch
Jan 1, 1981·Cancer·A B MillerA Winkler
Dec 30, 1996·Statistics in Medicine·E J Goetghebeur, S H Shapiro
May 15, 1997·Statistics in Medicine·J CuzickN Segnan
Apr 17, 2001·Annals of Internal Medicine·D MoherUNKNOWN CONSORT GROUP (Consolidated Standards of Reporting Trials)
Sep 28, 2001·Journal of the American Podiatric Medical Association·D MoherUNKNOWN CONSORT Group (Consolidated Standards of Reporting Trials)
Mar 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maria ButiRafael Esteban
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael W Fried
Mar 5, 2004·Annals of Internal Medicine·Stephanos J HadziyannisUNKNOWN PEGASYS International Study Group

❮ Previous
Next ❯

Citations

Oct 21, 2005·The Journal of Molecular Diagnostics : JMD·Elena Rodríguez-IñigoVicente Carreño
Feb 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Holly HaganUNKNOWN Study to Reduce Intravenous Exposures Project Team
Jan 14, 2011·Journal of Gastroenterology and Hepatology·Kazuaki Chayama, C Nelson Hayes
Nov 20, 2012·BMC Gastroenterology·Adriano M PellicelliUNKNOWN CLEO Group
Sep 28, 2013·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Yoshimichi Haruna, Atsuo Inoue
Dec 6, 2011·Digestive Diseases and Sciences·John Carl HoefsBernard Joseph Ilagan
Nov 22, 2005·Expert Opinion on Drug Delivery·Michael J GraceRonald W Bordens
Feb 2, 2010·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Hidenori ToyodaMasashi Fujimori
Aug 14, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stuart K RobertsUNKNOWN Chariot Study Group
Mar 27, 2007·Journal of Viral Hepatitis·A Mangia
Aug 24, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Naoki HiramatsuNorio Hayashi
Sep 7, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Hirohisa YanoMasamichi Kojiro
Apr 28, 2012·Microbiology and Immunology·Satomi KaniMasashi Mizokami
Mar 30, 2005·Expert Opinion on Pharmacotherapy·Calogero CammàAntonio Craxì
Nov 17, 2009·Journal of Hepatology·Antonio Craxì
May 28, 2005·Expert Review of Anti-infective Therapy·Stephen Chihrin, Mona R Loutfy
Jun 15, 2006·The American Journal of Gastroenterology·Edward L KrawittUNKNOWN New York New England Study Team
Mar 4, 2014·The Cochrane Database of Systematic Reviews·Goran HauserLise Lotte Gluud
Dec 12, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alessandra MangiaAngelo Andriulli
Jan 17, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Roseann S GammalGeorge M Abraham

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
K L LindsayHepatitis Interventional Therapy Group
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association
R S GarfeinD Vlahov
© 2021 Meta ULC. All rights reserved